Skip to main content

Cetera Trust Company, N.A

SEC CIK
0002005547
Latest filing
Aug 13, 2026

The latest 13F from Cetera Trust Company, N.A covers Q2 2026 (filed Aug 13, 2026): 345 long positions worth $199.3M. The top 10 holdings make up 32.5% of the portfolio, and the largest is Lam Research Corp (LRCX) at 7.8%. Livermore has 11 filings on Form 13F from this institution, going back to Q4 2023.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
3
Est. +$785.7K
Added
65
Est. +$1.15M
Reduced
35
Est. −$1.90M
Sold out
9
Est. −$2.55M

Top 5 holdings

Share of this quarter's portfolio value

  1. LRCXLam Research Corp
    7.8%$15.5MHistory
  2. AAPLApple Inc.
    5.7%$11.4MHistory
  3. GOOGLAlphabet Inc.
    2.9%$5.87MHistory
  4. JPMJPMorgan Chase & Co
    2.6%$5.23MHistory
  5. MSFTMicrosoft Corp
    2.5%$4.91MHistory

Share of portfolio

Top 5 holdings and the other 340 positions, by share of portfolio value

  1. LRCX7.8%
  2. AAPL5.7%
  3. GOOGL2.9%
  4. JPM2.6%
  5. MSFT2.5%
  6. Other 340 positions78.4%

Biggest buys

New and added positions, by estimated amount bought

  1. AZNAstraZeneca PLC
    +$449.2KNewHistory
  2. PNFPPinnacle Financial Partners, Inc.
    +$329.8KNewHistory
  3. UNHUnitedHealth Group Inc
    +$83.1KAddedHistory
  4. ELVElevance Health, Inc.
    +$61.9KAddedHistory
  5. BKNGBooking Holdings Inc.
    +$53.5KAddedConverted for a 25-for-1 splitHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. COHRCoherent Corp.
    +0.31 pp0.6% → 1.0%History
  2. UNHUnitedHealth Group Inc
    +0.30 pp0.7% → 1.0%History
  3. AZNAstraZeneca PLC
    +0.23 pp0.0% → 0.2%History
  4. PNFPPinnacle Financial Partners, Inc.
    +0.17 pp0.0% → 0.2%History
  5. LGNDLigand Pharmaceuticals Inc
    +0.14 pp0.3% → 0.5%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. HONHoneywell International Inc
    −$2.43MSold outHistory
  2. LRCXLam Research Corp
    −$411.7KReducedHistory
  3. LPROOpen Lending Corp
    −$223.9KReducedHistory
  4. PHMPultegroup Inc
    −$150.5KReducedHistory
  5. GOOGLAlphabet Inc.
    −$101.9KReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. HONHoneywell International Inc
    −1.37 pp1.4% → 0.0%History
  2. MCKMcKesson Corp
    −0.67 pp2.9% → 2.3%History
  3. WMTWalmart Inc.
    −0.57 pp2.8% → 2.3%History
  4. FDXFedEx Corp
    −0.35 pp1.5% → 1.2%History
  5. HCAHCA Healthcare, Inc.
    −0.26 pp0.8% → 0.6%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$199.3M
+$22.4M (+12.7%) vs. prior quarter
Positions
345
−6 vs. prior quarter
Top 10 concentration
32.5%
Top 10 as share of value
Turnover
1.0%
Q2 2026, one quarter
Average holding period
10.2 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2023), so positions held before then are understated.

13F filings by quarter

11 quarters, going back to Q4 2023. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $199.3M (Q2 2026)

Q4 2023: $160.5MQ1 2024: $166.2MQ2 2024: $159.3MQ3 2024: $163.5MQ4 2024: $154.0MQ1 2025: $156.9MQ2 2025: $167.5MQ3 2025: $178.6MQ4 2025: $187.0MQ1 2026: $176.9MQ2 2026: $199.3M
Q4 2023Q2 2026
13F filings of Cetera Trust Company, N.A by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 13, 2026345$199.3MLRCXAAPLGOOGLvs. Q1 2026SEC
Q1 2026May 8, 2026351$176.9MAAPLLRCXMCKvs. Q4 2025SEC
Q4 2025Feb 13, 2026358$187.0MAAPLLRCXMSFTvs. Q3 2025SEC
Q3 2025Nov 13, 2025353$178.6MAAPLMSFTLRCXvs. Q2 2025SEC
Q2 2025Aug 6, 2025359$167.5MAAPLMSFTJPMvs. Q1 2025SEC
Q1 2025Apr 14, 2025373$156.9MAAPLMSFTMCKvs. Q4 2024SEC
Q4 2024Jan 17, 2025387$154.0MAAPLMSFTAMZNvs. Q3 2024SEC
Q3 2024Oct 21, 2024400$163.5MAAPLMSFTAMZNvs. Q2 2024SEC
Q2 2024Aug 2, 2024408$159.3MAAPLMSFTLRCXvs. Q1 2024SEC
Q1 2024May 8, 2024414$166.2MAAPLMSFTLRCXvs. Q4 2023SEC
Q4 2023Feb 1, 2024419$160.5MAAPLMSFTLRCX–SEC